Video

Anthony Rothschild, MD, Discusses How Healthcare Barriers Can Keep Patients From Antipsychotics

Anthony J. Rothschild, MD, says that barriers to expensive antipsychotic drugs are shortsighted. He adds that the American Psychiatric Association, in accordance with some in Congress, recently rejected a CMS decision that would have restricted the number of antidepressants and antipsychotics Medicare beneficiaries could receive.

Anthony J. Rothschild, MD, says that barriers to expensive antipsychotic drugs are shortsighted. He adds that the American Psychiatric Association, in accordance with some in Congress, recently rejected a CMS decision that would have restricted the number of antidepressants and antipsychotics Medicare beneficiaries could receive.

Dr Rothschild is professor and Irving S. and Betty Brudnick Endowed Chair of Psychiatry, University of Massachusetts Medical School; director, UMass Medical Depression Center and Center for Psychopharmacologic Research and Treatment, and program director, Mood Disorders Comprehensive Consultation Clinic at UMass Memorial Medical Center.

“The bottom line is—whether it’s the state’s Medicaid or the federal government on Medicare—is that the amount of money you save on the price of the pill is small compared to the amount of money you might save by giving effective medications, because people are using less healthcare services, both mental and physical,” says Dr Rothschild.

Related Videos
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Marla Black Morgan, MD, Phoebe Neurology Associates
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD
Galen Shearn-Nance, BS
Dr Johnie Rose
Bridgette Picou, LVN, ACLPN, The Well Project
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Richard Nowak, MD, MS, Yale School of Medicine
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo